author_facet Ghosh, Subrata K.
Wood, Charles
Boise, Lawrence H.
Mian, Abdul M.
Deyev, Vadim V.
Feuer, Gerold
Toomey, Ngoc L.
Shank, Nicole C.
Cabral, Lisa
Barber, Glen N.
Harrington, William J.
Ghosh, Subrata K.
Wood, Charles
Boise, Lawrence H.
Mian, Abdul M.
Deyev, Vadim V.
Feuer, Gerold
Toomey, Ngoc L.
Shank, Nicole C.
Cabral, Lisa
Barber, Glen N.
Harrington, William J.
author Ghosh, Subrata K.
Wood, Charles
Boise, Lawrence H.
Mian, Abdul M.
Deyev, Vadim V.
Feuer, Gerold
Toomey, Ngoc L.
Shank, Nicole C.
Cabral, Lisa
Barber, Glen N.
Harrington, William J.
spellingShingle Ghosh, Subrata K.
Wood, Charles
Boise, Lawrence H.
Mian, Abdul M.
Deyev, Vadim V.
Feuer, Gerold
Toomey, Ngoc L.
Shank, Nicole C.
Cabral, Lisa
Barber, Glen N.
Harrington, William J.
Blood
Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
Cell Biology
Hematology
Immunology
Biochemistry
author_sort ghosh, subrata k.
spelling Ghosh, Subrata K. Wood, Charles Boise, Lawrence H. Mian, Abdul M. Deyev, Vadim V. Feuer, Gerold Toomey, Ngoc L. Shank, Nicole C. Cabral, Lisa Barber, Glen N. Harrington, William J. 1528-0020 0006-4971 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2002-08-2525 <jats:p>The survival of viral mediated lymphomas depends upon constitutive nuclear factor kappa B (NF-κB) activity. AIDS-related human herpesvirus type 8–associated primary effusion lymphoma (PEL) responds poorly to chemotherapy and is almost invariably fatal. We have previously demonstrated that the antiviral combination of interferon alpha (IFN-α) and azidothymidine (AZT) induces apoptosis in PEL cell lines. We therefore used these agents as therapy for an AIDS patient with PEL. The patient had a dramatic response, with complete resolution of his malignant effusion in 5 days. In PEL cells, the death receptor ligand known as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is markedly up-regulated by IFN-α; however, signals transduced by death receptors may also activate an antiapoptotic response mediated by NF-κB. In both the primary tumor cells from our patient and PEL cell lines, AZT selectively blocked nuclear entry of the NF-κB heterodimer p50 and p65, an effect not seen with other nonthymidine antiviral nucleosides. AZT monophosphate, the principal intracellular metabolite, inhibited phosphorylation and degradation of IκB by the IκB kinase complex. AZT- and IFN-α-mediated apoptosis was blocked by expression and nuclear localization of an IκB-resistant form of NF-κB (the p50 subunit linked to the transactivation domain of herpes simplex virus VP16). The proapoptotic effect of AZT and IFN-α in PEL occurs through the concomitant activation of TRAIL and blockade of NF-κB and represents a novel antiviral therapy for a virally mediated tumor.</jats:p> Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB Blood
doi_str_mv 10.1182/blood-2002-08-2525
facet_avail Online
Free
finc_class_facet Biologie
Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDAyLTA4LTI1MjU
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDAyLTA4LTI1MjU
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
DE-14
DE-105
DE-Ch1
DE-L229
imprint American Society of Hematology, 2003
imprint_str_mv American Society of Hematology, 2003
issn 1528-0020
0006-4971
issn_str_mv 1528-0020
0006-4971
language English
mega_collection American Society of Hematology (CrossRef)
match_str ghosh2003potentiationoftrailinducedapoptosisinprimaryeffusionlymphomathroughazidothymidinemediatedinhibitionofnfkb
publishDateSort 2003
publisher American Society of Hematology
recordtype ai
record_format ai
series Blood
source_id 49
title Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_unstemmed Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_full Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_fullStr Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_full_unstemmed Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_short Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_sort potentiation of trail-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of nf-κb
topic Cell Biology
Hematology
Immunology
Biochemistry
url http://dx.doi.org/10.1182/blood-2002-08-2525
publishDate 2003
physical 2321-2327
description <jats:p>The survival of viral mediated lymphomas depends upon constitutive nuclear factor kappa B (NF-κB) activity. AIDS-related human herpesvirus type 8–associated primary effusion lymphoma (PEL) responds poorly to chemotherapy and is almost invariably fatal. We have previously demonstrated that the antiviral combination of interferon alpha (IFN-α) and azidothymidine (AZT) induces apoptosis in PEL cell lines. We therefore used these agents as therapy for an AIDS patient with PEL. The patient had a dramatic response, with complete resolution of his malignant effusion in 5 days. In PEL cells, the death receptor ligand known as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is markedly up-regulated by IFN-α; however, signals transduced by death receptors may also activate an antiapoptotic response mediated by NF-κB. In both the primary tumor cells from our patient and PEL cell lines, AZT selectively blocked nuclear entry of the NF-κB heterodimer p50 and p65, an effect not seen with other nonthymidine antiviral nucleosides. AZT monophosphate, the principal intracellular metabolite, inhibited phosphorylation and degradation of IκB by the IκB kinase complex. AZT- and IFN-α-mediated apoptosis was blocked by expression and nuclear localization of an IκB-resistant form of NF-κB (the p50 subunit linked to the transactivation domain of herpes simplex virus VP16). The proapoptotic effect of AZT and IFN-α in PEL occurs through the concomitant activation of TRAIL and blockade of NF-κB and represents a novel antiviral therapy for a virally mediated tumor.</jats:p>
container_issue 6
container_start_page 2321
container_title Blood
container_volume 101
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792347732520730634
geogr_code not assigned
last_indexed 2024-03-01T17:59:46.337Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Potentiation+of+TRAIL-induced+apoptosis+in+primary+effusion+lymphoma+through+azidothymidine-mediated+inhibition+of+NF-%CE%BAB&rft.date=2003-03-15&genre=article&issn=0006-4971&volume=101&issue=6&spage=2321&epage=2327&pages=2321-2327&jtitle=Blood&atitle=Potentiation+of+TRAIL-induced+apoptosis+in+primary+effusion+lymphoma+through+azidothymidine-mediated+inhibition+of+NF-%CE%BAB&aulast=Harrington&aufirst=William+J.&rft_id=info%3Adoi%2F10.1182%2Fblood-2002-08-2525&rft.language%5B0%5D=eng
SOLR
_version_ 1792347732520730634
author Ghosh, Subrata K., Wood, Charles, Boise, Lawrence H., Mian, Abdul M., Deyev, Vadim V., Feuer, Gerold, Toomey, Ngoc L., Shank, Nicole C., Cabral, Lisa, Barber, Glen N., Harrington, William J.
author_facet Ghosh, Subrata K., Wood, Charles, Boise, Lawrence H., Mian, Abdul M., Deyev, Vadim V., Feuer, Gerold, Toomey, Ngoc L., Shank, Nicole C., Cabral, Lisa, Barber, Glen N., Harrington, William J., Ghosh, Subrata K., Wood, Charles, Boise, Lawrence H., Mian, Abdul M., Deyev, Vadim V., Feuer, Gerold, Toomey, Ngoc L., Shank, Nicole C., Cabral, Lisa, Barber, Glen N., Harrington, William J.
author_sort ghosh, subrata k.
container_issue 6
container_start_page 2321
container_title Blood
container_volume 101
description <jats:p>The survival of viral mediated lymphomas depends upon constitutive nuclear factor kappa B (NF-κB) activity. AIDS-related human herpesvirus type 8–associated primary effusion lymphoma (PEL) responds poorly to chemotherapy and is almost invariably fatal. We have previously demonstrated that the antiviral combination of interferon alpha (IFN-α) and azidothymidine (AZT) induces apoptosis in PEL cell lines. We therefore used these agents as therapy for an AIDS patient with PEL. The patient had a dramatic response, with complete resolution of his malignant effusion in 5 days. In PEL cells, the death receptor ligand known as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is markedly up-regulated by IFN-α; however, signals transduced by death receptors may also activate an antiapoptotic response mediated by NF-κB. In both the primary tumor cells from our patient and PEL cell lines, AZT selectively blocked nuclear entry of the NF-κB heterodimer p50 and p65, an effect not seen with other nonthymidine antiviral nucleosides. AZT monophosphate, the principal intracellular metabolite, inhibited phosphorylation and degradation of IκB by the IκB kinase complex. AZT- and IFN-α-mediated apoptosis was blocked by expression and nuclear localization of an IκB-resistant form of NF-κB (the p50 subunit linked to the transactivation domain of herpes simplex virus VP16). The proapoptotic effect of AZT and IFN-α in PEL occurs through the concomitant activation of TRAIL and blockade of NF-κB and represents a novel antiviral therapy for a virally mediated tumor.</jats:p>
doi_str_mv 10.1182/blood-2002-08-2525
facet_avail Online, Free
finc_class_facet Biologie, Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDAyLTA4LTI1MjU
imprint American Society of Hematology, 2003
imprint_str_mv American Society of Hematology, 2003
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229
issn 1528-0020, 0006-4971
issn_str_mv 1528-0020, 0006-4971
language English
last_indexed 2024-03-01T17:59:46.337Z
match_str ghosh2003potentiationoftrailinducedapoptosisinprimaryeffusionlymphomathroughazidothymidinemediatedinhibitionofnfkb
mega_collection American Society of Hematology (CrossRef)
physical 2321-2327
publishDate 2003
publishDateSort 2003
publisher American Society of Hematology
record_format ai
recordtype ai
series Blood
source_id 49
spelling Ghosh, Subrata K. Wood, Charles Boise, Lawrence H. Mian, Abdul M. Deyev, Vadim V. Feuer, Gerold Toomey, Ngoc L. Shank, Nicole C. Cabral, Lisa Barber, Glen N. Harrington, William J. 1528-0020 0006-4971 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2002-08-2525 <jats:p>The survival of viral mediated lymphomas depends upon constitutive nuclear factor kappa B (NF-κB) activity. AIDS-related human herpesvirus type 8–associated primary effusion lymphoma (PEL) responds poorly to chemotherapy and is almost invariably fatal. We have previously demonstrated that the antiviral combination of interferon alpha (IFN-α) and azidothymidine (AZT) induces apoptosis in PEL cell lines. We therefore used these agents as therapy for an AIDS patient with PEL. The patient had a dramatic response, with complete resolution of his malignant effusion in 5 days. In PEL cells, the death receptor ligand known as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is markedly up-regulated by IFN-α; however, signals transduced by death receptors may also activate an antiapoptotic response mediated by NF-κB. In both the primary tumor cells from our patient and PEL cell lines, AZT selectively blocked nuclear entry of the NF-κB heterodimer p50 and p65, an effect not seen with other nonthymidine antiviral nucleosides. AZT monophosphate, the principal intracellular metabolite, inhibited phosphorylation and degradation of IκB by the IκB kinase complex. AZT- and IFN-α-mediated apoptosis was blocked by expression and nuclear localization of an IκB-resistant form of NF-κB (the p50 subunit linked to the transactivation domain of herpes simplex virus VP16). The proapoptotic effect of AZT and IFN-α in PEL occurs through the concomitant activation of TRAIL and blockade of NF-κB and represents a novel antiviral therapy for a virally mediated tumor.</jats:p> Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB Blood
spellingShingle Ghosh, Subrata K., Wood, Charles, Boise, Lawrence H., Mian, Abdul M., Deyev, Vadim V., Feuer, Gerold, Toomey, Ngoc L., Shank, Nicole C., Cabral, Lisa, Barber, Glen N., Harrington, William J., Blood, Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB, Cell Biology, Hematology, Immunology, Biochemistry
title Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_full Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_fullStr Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_full_unstemmed Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_short Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
title_sort potentiation of trail-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of nf-κb
title_unstemmed Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
topic Cell Biology, Hematology, Immunology, Biochemistry
url http://dx.doi.org/10.1182/blood-2002-08-2525